When Insurance Says ‘No’
By Codi Darnell November 1, 2022 As a society, we’ve gotten to a place where we have insurance for everything. From homes and vehicles to travel, pets, and health, we take out policies and spend thousands of dollars each year because we believe it means we’re protected. We sleep better at night thinking we are […]
NervGen Engages Cloutier Consulting to Provide Media Relations Services
Vancouver, Canada. October 31, 2022 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced that it has engaged Cloutier Consulting, a Texas based public relations specialty agency, to provide media relations and related services for the Company. […]
NervGen Pharma Receives FDA Authorization to Expand Enrollment of Males and Premenopausal Females in Phase 1 Clinical Trial of NervGen’s NVG-291
Dose(s) to be tested in bridging cohorts of males and premenopausal females resulted in significant functional improvements in animal models of nervous system damage NervGen has completed enrollment of third and final multiple ascending dose cohort of postmenopausal women Vancouver, Canada. October 25, 2022 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a […]
NervGen Pharma Presenting at Upcoming Scientific Meetings
AMERICAN NEUROLOGICAL ASSOCIATION ANNUAL MEETING EUROPEAN COMMITTEE FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS Vancouver, Canada. October 20, 2022 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, will be presenting posters at two upcoming scientific meetings […]
Navigating New Motherhood in the Aftermath of a Stroke
By Codi Darnell October 18, 2022 Everyone experiences events that alter the course of their life; many of them are embraced: the chance encounters that turn into long-term partnerships; the arrival of a child that transforms you into a parent; the job offer that kickstarts your career. But there are others we hope to avoid […]
NervGen Pharma Awarded up to $1.5 Million US Department of Defense Funding to Evaluate NervGen’s NVG-291-R for Peripheral Nerve Injury
The $1.5 million award is to evaluate the ability of NervGen’s NVG-291-R to accelerate and enhance restoration of function following peripheral nerve injury (PNI) The research is to support a potential game changing therapeutic approach to restore function for US military service members and the estimated 20+ million Americans suffering from PNI There are currently […]
Make Trick-or-Treating Accessible
By Codi Darnell October 4, 2022 For many children around the world, trick-or-treating is a rite of passage. Come October 31st, neighbourhoods fill up with parading princesses, werewolves, PAW Patrol pups, and stormtroopers, all with one common goal: knock on all the doors and fill up your bag with as many goodies as you can. […]
NervGen Pharma Announces Results of Annual General Meeting of Shareholders
All resolutions submitted for approval were passed by shareholders Vancouver, Canada, September 29, 2022 — NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF), a clinical stage biotech company dedicated to developing a first-in-class neuroreparative drug to treat nervous system damage, announces the results of its Annual General Meeting of Shareholders (“AGM”) held on September 28, 2022. “We appreciate […]
4 Activities to Engage People with Alzheimer’s
By Codi Darnell September 20, 2022 What Are We Going To Do Today? If you have woken up and asked yourself this question on a regular basis, you are probably a caregiver. And while a large part of caregiving is based around managing physical needs, there is also a responsibility to engage and stimulate a […]
NervGen Pharma Announces Appointment of Dr. Matvey Lukashev as Vice President, Research and Preclinical Development
Expands research capabilities aiming to build pipeline of proprietary compounds for nervous system repair Lukashev brings over 20 years’ experience including work at Biogen and the ALS Therapy Development Institute Vancouver, Canada. September 12, 2022 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing innovative solutions […]